Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection

Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection

Author Nucci, M. Google Scholar
Anaissie, E. J. Google Scholar
Queiroz-Telles, F. Google Scholar
Martins, C. A. Google Scholar
Trabasso, P. Google Scholar
Solza, C. Google Scholar
Mangini, C. Google Scholar
Simoes, B. P. Google Scholar
Colombo, Arnaldo Lopes Autor UNIFESP Google Scholar
Vaz, J. Google Scholar
Levy, C. E. Google Scholar
Costa, S. Google Scholar
Moreira, V. A. Google Scholar
Oliveira, José Salvador Rodrigues de Autor UNIFESP Google Scholar
Paraguay, N. Google Scholar
Duboc, G. Google Scholar
Voltarelli, J. C. Google Scholar
Maiolino, A. Google Scholar
Pasquini, R. Google Scholar
Souza, C. A. Google Scholar
Institution Univ Arkansas Med Sci
Universidade Federal do Rio de Janeiro (UFRJ)
Univ Fed Parana
Inst Nacl Canc
Universidade Estadual de Campinas (UNICAMP)
Universidade do Estado do Rio de Janeiro (UERJ)
Hosp Canc
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Hosp Santa Lucia
Ctr Infantil Boldrini
Abstract BACKGROUND. invasive infection by Fusarium sp. is associated with high mortality in patients with hematologic cancer. Yet to the authors' knowledge, little is known regarding predictors of adverse outcome.METHODS. the authors conducted a retrospective review of the records of patients with hematologic carcinoma and invasive fusariosis who were treated at one institution in the U.S. and at 11 centers in Brazil.RESULTS. the records of 84 patients were evaluated. Neutropenia was present in 83% and 33 patients had undergone stem cell transplantation. Only 18 patients (21%) were alive 90 days after the diagnosis of fusariosis. Multivariate predictors of poor outcome were persistent neutropenia (hazard ratio [HR] of 5.43; 95% confidence interval [95% Cl], 2.64-11.11) and use of corticosteroids (HR of 2.18; 95% Cl, 1.98-3.96). the actuarial survival rate of patients without any of these factors was 67% compared with 30% for patients who recovered from neutropenia but were receiving corticosteroids and 4% for patients with persistent neutropenia only. None of the patients with both risk factors survived (P < 0.0001).CONCLUSIONS. Measures to reduce the duration of neutropenia, as well as the judicious use of corticosteroids, may reduce the high mortality rate of fusariosis in patients with hematologic cancer. (C) 2003 American Cancer Society.
Keywords fusarium
fusariosis
cancer
prognostic factor
mortality
Language English
Date 2003-07-15
Published in Cancer. Hoboken: John Wiley & Sons Inc, v. 98, n. 2, p. 315-319, 2003.
ISSN 0008-543X (Sherpa/Romeo, impact factor)
Publisher Wiley-Blackwell
Extent 315-319
Origin http://dx.doi.org/10.1002/cncr.11510
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000183944300015
URI http://repositorio.unifesp.br/handle/11600/27323

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account